Potent activity of indolequinones against human pancreatic cancer: identification of thioredoxin reductase as a potential target.
about
A survey on the computational approaches to identify drug targets in the postgenomic eraMechanism-Based Inhibition of Quinone Reductase 2 (NQO2): Selectivity for NQO2 over NQO1 and Structural Basis for Flavoprotein InhibitionThe Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic CancersAlteration of thioredoxin reductase 1 levels in elucidating cancer etiology.Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling.Antitumour indolequinones: synthesis and activity against human pancreatic cancer cellsDesign and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanismDose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model.Synthesis of 3-substituted indoles via reactive alkylideneindolenine intermediates.Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine.Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation.
P2860
Q27003870-E0E8EC94-9378-436D-863A-217148B7EFABQ27667472-AE043B7E-06DE-453D-8130-DFB6047596C9Q28551531-25A2C0FC-5FB3-4DCF-B84C-B1B16413D4B4Q34931100-88E66496-4699-4330-8918-B6F1E1C42DD2Q35776738-65907629-AECD-4796-A638-AD1E2307A603Q35831668-24E626D0-2A34-45F7-A498-2F4AD3CBF6FCQ35889278-746A0ACE-5ECF-4120-A3B8-894BCA248335Q36430099-D6E6E85E-AFCA-4AB1-B00A-BDA7DF4C9149Q37642550-F2C23C67-530C-4CAB-BC26-F7C6B47D6BE5Q37702824-B86B3984-25DA-4644-BA8A-455F7FA6B527Q39166075-1DB2E3A3-2665-4D08-B7DD-A09A45364D29Q53292207-20EE5F64-FFF6-4174-A92F-47FEBB7E37E1
P2860
Potent activity of indolequinones against human pancreatic cancer: identification of thioredoxin reductase as a potential target.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potent activity of indolequino ...... ductase as a potential target.
@en
Potent activity of indolequino ...... ductase as a potential target.
@nl
type
label
Potent activity of indolequino ...... ductase as a potential target.
@en
Potent activity of indolequino ...... ductase as a potential target.
@nl
prefLabel
Potent activity of indolequino ...... ductase as a potential target.
@en
Potent activity of indolequino ...... ductase as a potential target.
@nl
P2093
P2860
P356
P1476
Potent activity of indolequino ...... ductase as a potential target.
@en
P2093
Aurélie Chilloux
Biehuoy Shieh
David Ross
David Siegel
Jeffery J Newsome
Marie A Colucci
Philip Reigan
Zhiyong Zhang
P2860
P304
P356
10.1124/MOL.109.055855
P577
2009-04-13T00:00:00Z